KRAS WT pancreatic adenocarcinomas: Another disease?

被引：0
|
作者：
Ben-Ammar, Imen
Ducreux, Michel
Boige, Valerie
Hollebecque, Antoine
Tarabay, Anthony
Smolenschi, Cristina
Gelli, Maximiliano
Tanguy, Marie Laure
Valery, Marine
Rouleau, Etienne
Barbe, Remy
Boileve, Alice
Fuerea, Alina Cristina
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Gustave Roussy, Paris, France
[3] Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
750
引用
收藏
页码：750 / 750
页数：1
相关论文
共 50 条
  • [1] Precision medicine for KRAS wild-type pancreatic adenocarcinomas
    Ben-Ammar, Imen
    Rousseau, Adrien
    Nicolle, Remy
    Tarabay, Anthony
    Boige, Valerie
    Valery, Marine
    Pudlarz, Thomas
    Malka, David
    Gelli, Maximiliano
    Fernandez-De-Sevilla, Elena
    Fuerea, Alina
    Tanguy, Marie-Laure
    Rouleau, Etienne
    Barbe, Remy
    Mathieu, Jacques R. R.
    Jaulin, Fanny
    Smolenschi, Cristina
    Hollebecque, Antoine
    Ducreux, Michel
    Boileve, Alice
    EUROPEAN JOURNAL OF CANCER, 2024, 197
  • [2] Mutations in KRAS: are they a valid biomarker for pancreatic ductal adenocarcinomas diagnosis?
    Narayanan, Vilvapathy
    Konstantinov, Sergey R.
    Peppelenbosch, Maikel P.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S72 - S77
  • [3] RAF/MEK Dependence of KRAS-Mutant Pancreatic Ductal Adenocarcinomas
    Hanrahan, Aphrothiti J.
    Solit, David B.
    CANCER DISCOVERY, 2012, 2 (08) : 666 - 669
  • [4] KRAS CODON-12 MUTATIONS OCCUR VERY FREQUENTLY IN PANCREATIC ADENOCARCINOMAS
    SMIT, VTHBM
    BOOT, AJM
    SMITS, AMM
    FLEUREN, GJ
    CORNELISSE, CJ
    BOS, JL
    NUCLEIC ACIDS RESEARCH, 1988, 16 (16) : 7773 - 7782
  • [5] The tumor microenvironment and immune infiltration landscape of KRAS mutant pancreatic ductal adenocarcinomas (PDAC) compared to colorectal adenocarcinomas (CRC).
    Lou, Emil
    Xiu, Joanne
    Baca, Yasmine
    Walker, Phillip
    Manji, Gulam Abbas
    Gholami, Sepideh
    Saeed, Anwaar
    Philip, Philip Agop
    Prakash, Ajay
    Astsaturov, Igor A.
    Botta, Greg
    Abushahin, Laith I.
    Sohal, Davendra
    Lenz, Heinz Josef
    Shields, Anthony Frank
    Nabhan, Chadi
    El Deiry, Wafik S.
    Seeber, Andreas
    Korn, Wolfgang Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Not all treated KRAS-mutant pancreatic adenocarcinomas are equal: KRAS G12D and survival outcome
    Ardalan, Bach
    Ciner, Aaron
    Baca, Yasmine
    Darabi, Sourat
    Kasi, Anup
    Lou, Emil
    Azqueta, Jose Ignacio
    Xiu, Joanne
    Nabhan, Chadi
    Shields, Anthony F.
    Aguirre, Andrew
    Singh, Harshabad
    Shroff, Rachna T.
    Pishvaian, Michael J.
    Goel, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] KRAS, BRAS mutations, and HER2 expression in patients operated for pancreatic adenocarcinomas
    Schultz, N. A.
    Roslind, A.
    Heeran, M.
    Christensen, I. J.
    Hogdall, E. V.
    Horn, T.
    Wojdemann, M.
    Balslev, E.
    Johansen, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] KRAS mutations in pulmonary adenocarcinomas
    Sousa, V.
    Alarcao, A.
    Ladeirinha, A. F.
    Reis Silva, M.
    Ferreira, T.
    Viseu, M.
    Santos, M. A.
    Pimentel, J.
    Nogueira Fontinha, G.
    Almeida, V.
    Carvalho, L.
    VIRCHOWS ARCHIV, 2024, 485 : S432 - S432
  • [9] Frequencies and Prognostic Role of KRAS and BRAF Mutations in Patients With Localized Pancreatic and Ampullary Adenocarcinomas
    Schultz, Nicolai Aagaard
    Roslind, Anne
    Christensen, Ib J.
    Horn, Thomas
    Hogdall, Estrid
    Pedersen, Lisbeth N.
    Kruhoffer, Mogens
    Burcharth, Flemming
    Wojdemann, Morten
    Johansen, Julia S.
    PANCREAS, 2012, 41 (05) : 759 - 766
  • [10] KRAS Amplification Is Restricted to KRAS Mutated Lung Adenocarcinomas
    Chiosea, S.
    Sherer, C.
    Dacic, S.
    MODERN PATHOLOGY, 2011, 24 : 406A - 406A
12345